Mucus Relief Extended Release Tablet, Extended Release
Product Images NDC 0536-1163

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mucus Relief Extended Release (NDC 0536-1163). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rugby Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Guaifenesin 600 mg (Mucus Relief 600 mg Extended Release Caplets 1)

Guaifenesin 600 mg (Mucus Relief 600 mg Extended Release Caplets 1)
This is a drug information sheet for extended-release tablets containing 610 g guaifenesin as an expectorant. It is used to help loosen phlegm and make coughs more productive. The product should not be given to children under 12 years of age, and pregnant or breastfeeding women should consult a healthcare professional before use. The directions for use include taking one to two tablets every 12 hours for children aged 12 years and above, without regard to food. The product should not be crushed, chewed, or broken. In case of an overdose, contact Poison Control immediately. The inactive ingredients include carbomer, colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, povidone, and sodium starch glycolate. This product is manufactured by Rugby Laboratories and distributed by Bookstone LLC.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.